Company Description
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment.
It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.
In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair.
Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products.
Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems.
It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally.
Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995.
Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
| Country | United States |
| Founded | 1989 |
| IPO Date | Aug 16, 1995 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 4,427 |
| CEO | Mojdeh Poul |
Contact Details
Address: 1100 Campus Road Princeton, New Jersey 08540 United States | |
| Phone | 609-275-0500 |
| Website | integralife.com |
Stock Details
| Ticker Symbol | IART |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000917520 |
| CUSIP Number | 457985208 |
| ISIN Number | US4579852082 |
| Employer ID | 51-0317849 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Mojdeh Poul | President, Chief Executive Officer and Director |
| Lea Daniels Knight | Executive Vice President and Chief Financial Officer |
| Robert T. Davis Jr. | Executive Vice President and President of Tissue Technologies |
| Michael J. McBreen | Executive Vice President and President of Codman Specialty Surgical |
| Harvinder Pal Singh | Executive Vice President and President of International Business |
| Jeffrey A. Mosebrook | Senior Vice President of Finance and Principal Accounting Officer |
| Teshtar Elavia | Corporate Vice President and Chief Technology Officer |
| Christopher Ward | Senior Director of Investor Relations |
| Michael D. Hutchinson | Executive Vice President, Chief Legal Officer and Secretary |
| Laurene Isip | Vice President of Global Corporate Communications and Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 26, 2026 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
| Feb 26, 2026 | 10-K | Annual Report |
| Feb 26, 2026 | 8-K | Current Report |
| Feb 17, 2026 | SCHEDULE 13G/A | Filing |
| Dec 12, 2025 | 8-K | Current Report |
| Nov 6, 2025 | SCHEDULE 13G/A | Filing |
| Oct 30, 2025 | 10-Q | Quarterly Report |
| Oct 30, 2025 | 8-K | Current Report |
| Aug 5, 2025 | SCHEDULE 13G/A | Filing |
| Jul 31, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |